Journey Medical Corporati... (DERM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.73
-0.05 (-1.32%)
At close: Jan 14, 2025, 3:59 PM
3.73
0.00%
After-hours Jan 14, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Revenue | 79.18M | 73.67M | 63.13M | 44.53M | 34.92M | 42.34M | 4.54M | 22.59M | 7.30M | 7.30M |
Cost of Revenue | 26.66M | 30.77M | 32.08M | 14.59M | 10.53M | 1.18M | n/a | n/a | n/a | n/a |
Gross Profit | 52.52M | 42.89M | 31.05M | 29.94M | 24.39M | 41.16M | 4.54M | 22.59M | 7.30M | 7.30M |
Operating Income | -2.07M | -27.52M | -25.34M | 7.85M | 5.26M | -213.98M | -300.33M | -90.62M | -79.77M | -31.70M |
Interest Income | 322.00K | 60.00K | 2.00K | 698.00K | 255.00K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.63M | -29.57M | -42.36M | 7.15M | 5.00M | -221.73M | -303.26M | -89.08M | -79.02M | -31.84M |
Net Income | -3.85M | -29.63M | -43.99M | 5.28M | 3.63M | -221.54M | -303.26M | -89.08M | -78.40M | -31.88M |
Selling & General & Admin | 43.91M | 59.47M | 39.83M | 22.09M | 19.13M | 172.58M | 71.90M | 30.04M | 17.72M | 8.29M |
Research & Development | 7.54M | 10.94M | 16.56M | n/a | n/a | 80.55M | 104.41M | 83.17M | 66.83M | 30.71M |
Other Expenses | 3.14M | n/a | 23.36M | n/a | n/a | 2.02M | 128.56M | n/a | 2.52M | n/a |
Operating Expenses | 54.59M | 70.41M | 56.39M | 22.09M | 19.13M | 255.15M | 304.87M | 113.21M | 87.07M | 39.00M |
Interest Expense | 1.70M | 2.02M | 7.03M | 698.00K | 255.00K | 15.64M | 8.14M | 1.54M | 147.00K | 153.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 81.25M | 101.19M | 88.47M | 36.68M | 29.66M | 256.32M | 304.87M | 113.21M | 87.07M | 39.00M |
Income Tax | 221.00K | 63.00K | 1.63M | 1.87M | 1.38M | -194.00K | 5.21M | 3.08M | -622.00K | 31.00K |
Shares Outstanding (Basic) | 18.23M | 17.53M | 17.32M | 16.66M | 16.66M | 42.00M | 40.56M | 33.04M | 26.73M | 6.43M |
Shares Outstanding (Diluted) | 18.23M | 17.53M | 17.32M | 16.66M | 16.66M | 42.00M | 40.56M | 33.04M | 26.73M | 6.43M |
EPS (Basic) | -0.21 | -1.69 | -2.54 | 0.32 | 0.22 | -5.27 | -7.48 | -2.7 | -2.93 | -4.96 |
EPS (Diluted) | -0.21 | -1.69 | -2.54 | 0.32 | 0.22 | -5.27 | -7.48 | -2.7 | -2.93 | -4.96 |
EBITDA | 1.92M | -23.18M | -32.77M | 9.37M | 6.44M | -205.54M | -294.78M | -87.42M | -78.80M | -31.64M |
Depreciation & Amortization | 3.85M | 4.37M | 2.56M | 1.52M | 1.21M | 555.00K | 339.00K | 123.00K | 72.00K | 47.00K |